Heck Capital Advisors, LLC Pfizer Inc Transaction History

Heck Capital Advisors, LLC

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	BUY	$24.8 - $30.19 $45,855 - $55,821	1,849 New	1,849 $49.1 Million
Q4 2023 May 19, 2025	SELL	$26.13 - $33.94 $9,929 - $12,897	-380 Closed	0 $0
Q3 2023 May 19, 2025	BUY	$32.09 - $37.51 $12,194 - $14,253	380 New	380 $12.6 Million
Q2 2020 May 19, 2025	SELL	$30.12 - $36.54 $11,746 - $14,250	-390 Closed	0 $0
Q1 2020 May 19, 2025	SELL	$27.03 - $38.62 $124,554 - $177,960	-4,608 Reduced 92.2%	390 $12.7 Million

Q4 2019 May 19, 2025	BUY	$32.92 - $37.36 $6,024 - $6,836	183 Added 3.8%	4,998 $196 Million
Q3 2019 May 19, 2025	BUY	$32.49 - $42.13 $5,783 - $7,499	178 Added 3.84%	4,815 $173 Million
Q2 2019 May 19, 2025	BUY	$36.98 - $41.52 $6,286 - $7,058	170 Added 3.81%	4,637 $201 Million
Q1 2019 May 19, 2025	BUY	$37.5 - $41.2 $167,512 - $184,040	4,467 New	4,467 $190 Million
Q4 2018 May 19, 2025	SELL	$38.47 - $43.86 $3,346 - $3,815	-87 Reduced 1.98%	4,308 $188 Million
Q3 2018 May 19, 2025	SELL	$34.47 - $41.81 $9,100 - $11,037	-264 Reduced 5.67%	4,395 $194 Million
Q2 2018 May 19, 2025	BUY	$32.98 - $35.16 $791 - $843	24 Added 0.52%	4,659 $169 Million
Q1 2018 May 19, 2025	BUY	$31.91 - $37.02 $255 - $296	8 Added 0.17%	4,635 $164 Million
Q4 2017 May 19, 2025	BUY	$33.26 - $35.29 $831 - $882	25 Added 0.54%	4,627 $168 Million
Q3 2017 May 19, 2025	BUY	$31.0 - $34.15 $5,301 - $5,839	171 Added 3.86%	4,602 $164 Million
Q2 2017 May 19, 2025	SELL	N/A	-340 Reduced 7.13%	4,431 $149 Million
Q1 2017 May 19, 2025	BUY	N/A	4,771 New	4,771 $163 Million
Q4 2016 May 19, 2025	BUY	N/A	4,991	4,991 $162 Million

3,372

3.57B

86.1M

105M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Heck Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Heck Capital Advisors, LLC with notifications on news.